Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Weronika Fortuniak
Institutions:
Centrum Medyczne Kształcenia Podyplomowego,
The Maria Sklodowska-Curie National Research Institute of Oncology,
Samodzielny Publiczny Szpital Kliniczny im. prof. W. Orłowskiego CMKP
Observed institutions:
Centrum Medyczne Kształcenia Podyplomowego,
The Maria Sklodowska-Curie National Research Institute of Oncology,
Samodzielny Publiczny Szpital Kliniczny im. prof. W. Orłowskiego CMKP
ORCID:
0009-0006-4765-6164
Observed ORCID:
0009-0006-4765-6164
OpenAlex ID:
A5093894497
Analysis of Factors Contributing to Adverse Events and Evaluation of Their Impact on Prognosis in Metastatic Renal Cell Carcinoma Patients—Real-World Experience in a Single-Center Retrospective Study and Narrative Review
2024
·
Piotr Domański
, Mateusz Piętak
, et al.
·
Medicina
·
3
PDF
First experience in treating advanced urothelial cancer with enfortumab vedotin. Single-centre retrospective study of patients qualified for a rescue access procedure
2023
·
Bożena Sikora-Kupis
, Piotr Domański
, et al.
·
Współczesna Onkologia
·
3
PDF
JAK inhibitors in dermatology: Expanding indications and safety concerns
2025
·
Monika Karalus
, Alina Grudina
, et al.
·
Our Dermatology Online
·
2
PDF
Adjuvant analgesics in chronic pain therapy
2025
·
Adam Kobiernik
, Weronika Fortuniak
, et al.
·
Progress in Health Sciences
Analysis of adverse events associated with VEGFR-TKIs and their impact on prognosis in patients with mRCC — narrative review
2025
·
Piotr Domański
, Szymon Staneta
, et al.
·
Oncology in Clinical Practice
PDF
Harnessing marine microorganisms in the battle against the influenza virus
2025
·
Jakub Rezmer
, Inga Wasilewska
, et al.
·
Journal of Education Health and Sport
PDF
Show more works
View as search
Works count:
6
Citation count:
8
H-index:
2
I10-index:
Year
Topic
Type